Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations.
about
The significance of tumor-associated immune response in molecular taxonomy, prognosis and therapy of colorectal cancer patientsMolecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancerAssociation of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancerTowards the introduction of the 'Immunoscore' in the classification of malignant tumoursOpportunities for immunotherapy in microsatellite instable colorectal cancerHigh-content molecular profiling of T-cell therapy in oncologyBiomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and othersRole of modern immunotherapy in gastrointestinal malignancies: a review of current clinical progressT cell therapy targeting a public neoantigen in microsatellite instable colon cancer reduces in vivo tumor growth.Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.Nonsense mediated decay resistant mutations are a source of expressed mutant proteins in colon cancer cell lines with microsatellite instability.5-Fluorouracil response in a large panel of colorectal cancer cell lines is associated with mismatch repair deficiency.An MSI tumor specific frameshift mutation in a coding microsatellite of MSH3 encodes for HLA-A0201-restricted CD8+ cytotoxic T cell epitopesIdentification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).Immune genes are associated with human glioblastoma pathology and patient survival.Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature reviewRegulatory T lymphocytes are associated with less aggressive histologic features in microsatellite-unstable colorectal cancers.Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profilingMismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parameters.T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.Cancer immunology--analysis of host and tumor factors for personalized medicine.A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy.High lymph node yield is related to microsatellite instability in colon cancerFusobacterium nucleatum and T Cells in Colorectal Carcinoma.MicroRNA MIR21 and T Cells in Colorectal Cancer.Network-Based Enriched Gene Subnetwork Identification: A Game-Theoretic ApproachComprehensive genome- and transcriptome-wide analyses of mutations associated with microsatellite instability in Korean gastric cancers.Prognostic value of colorectal cancer biomarkers.Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotypeFatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway.Colorectal cancer and immunity: what we know and perspectives.Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI.A molecular portrait of microsatellite instability across multiple cancersNovel Therapies in Development for Metastatic Colorectal Cancer.Integrative Omics Analysis Reveals Post-Transcriptionally Enhanced Protective Host Response in Colorectal Cancers with Microsatellite Instability.Deficient Mismatch Repair and the Role of Immunotherapy in Metastatic Colorectal Cancer.The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities.Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.Anti program death-1/anti program death-ligand 1 in digestive cancers.Tumor-Infiltrating Lymphocytes, Crohn's-Like Lymphoid Reaction, and Survival From Colorectal Cancer.
P2860
Q26738665-2F753A5A-D8AF-450A-A25B-9462B9A8D888Q26769935-CAECFF49-AC1C-4A0A-B77F-874315FB61B3Q26774690-ABD33AE6-0E72-4230-82AD-2FFD2B3A9C51Q27026489-77E0120A-C5AA-40A0-ABBD-F3583D66E26DQ28066110-3A7A36CB-B80B-41FE-B1A9-623F6202AB1AQ28066792-697562A7-6847-4D0B-844E-351E140A8495Q28072468-A8757280-D081-44D4-8050-1530F1E7781EQ33593871-AED8DE14-69E1-403B-9474-14F95A02F6C5Q33632100-263579F5-92EE-41BF-AA3A-D72BDE46D3E4Q33728267-AFE607F2-FC5D-4351-8F3E-2D824870E496Q33786764-F1F9CFF0-54DB-42CB-861A-C04A82C22E1CQ34059750-E9E192EA-358A-498D-9ECF-7275D1985977Q34081414-0646AC34-905F-456C-9055-93FB62FBB927Q34106765-690E0335-3594-4325-9829-46BB892EA5E8Q34415093-224283E2-A247-4585-A5BC-44F67681529EQ34551974-64A8FD56-5616-4990-B12E-C8AA6628EA57Q34683929-76D8B149-929F-4649-AF2B-43C99804D9EDQ35070183-61E9320C-47DD-4DE9-A654-8080BB6DA83AQ35225280-BA604394-B443-4D0C-8791-5552547FB63FQ35550879-18E23657-8A4A-470E-83E5-E7131E7B4D07Q35583180-DBAB4566-575B-451A-B307-C543DDBA40A4Q35584153-45AE5BEA-3E24-4FB0-BC2A-C6B14651CD9EQ35843001-CEE2E63E-1F06-4886-A262-B163C61C19AFQ35956384-11D47764-8473-4B0D-BEC8-62CB32F7A449Q36436728-E84E4A8F-563B-4F7A-AD27-4028E459B05DQ36771143-AAC00843-F020-4D44-833C-88F980CE339DQ36973617-BB18BB78-DD99-448E-A0FA-E757C145B6BAQ37132721-1B19EDBA-4557-4083-96A1-BB7520F7C77BQ37407802-1729CB04-BA8E-4F1E-8A86-B59A2A6B7224Q37568540-F3E7E031-46EA-401D-894B-DB50D1F72024Q37697520-F8E15BB7-3A89-461D-8F88-C04CD1F504CFQ37880662-E10CC049-B260-4496-B600-3B5A7BA1E114Q38741312-E795AB79-279A-4ADC-9488-0B04C74CD48BQ38800472-6DB72449-5F8A-4FF6-B51D-DBBD6D2F1897Q38834632-167103B2-6670-4BA2-BEB3-E9F775FE38ADQ38868401-3A9EC623-5A97-4ED8-ACD2-8A437BCD2631Q39172481-3AC91ED5-1EC4-4F16-B32E-70090693659AQ39930421-18C0A76F-880C-4A8C-B699-92F3F3055EE4Q40608710-55FE7CD7-44F4-4B44-B7EF-612907F94789Q40757402-FD77928A-3EBA-4CBA-B5D7-591E801666ED
P2860
Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Tumor-infiltrating lymphocytes ...... ctrum of frameshift mutations.
@ast
Tumor-infiltrating lymphocytes ...... ctrum of frameshift mutations.
@en
Tumor-infiltrating lymphocytes ...... ctrum of frameshift mutations.
@nl
type
label
Tumor-infiltrating lymphocytes ...... ctrum of frameshift mutations.
@ast
Tumor-infiltrating lymphocytes ...... ctrum of frameshift mutations.
@en
Tumor-infiltrating lymphocytes ...... ctrum of frameshift mutations.
@nl
prefLabel
Tumor-infiltrating lymphocytes ...... ctrum of frameshift mutations.
@ast
Tumor-infiltrating lymphocytes ...... ctrum of frameshift mutations.
@en
Tumor-infiltrating lymphocytes ...... ctrum of frameshift mutations.
@nl
P2093
P2860
P1433
P1476
Tumor-infiltrating lymphocytes ...... ectrum of frameshift mutations
@en
P2093
Alexandre Rouquette
Emilie Fauquembergue
Florence Le Pessot
Frédéric Di Fiore
Jacques Mauillon
Jean-Baptiste Latouche
Jean-Christophe Sabourin
Mario Tosi
Michèle Laurent
Pascaline Berthet
P2860
P2888
P304
P356
10.1038/MODPATHOL.2009.80
P577
2009-06-05T00:00:00Z
P5875
P6179
1015474458